Paratek Pharmaceuticals, Inc.
PRTK
PRTK was delisted on the 20th of September, 2023.
36 hedge funds and large institutions have $12.8M invested in Paratek Pharmaceuticals, Inc. in 2014 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 7 closing their positions.
475% more call options, than puts
Call options by funds: $23K | Put options by funds: $4K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less funds holding
Funds holding: 39 → 36 (-3)
18% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 11
38% less capital invested
Capital invested by funds: $20.6M → $12.8M (-$7.74M)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$377K |
| 2 |
SG Americas Securities
New York
|
+$126K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$72K |
| 4 |
CL
CSS LLC
Chicago,
Illinois
|
+$55.5K |
| 5 |
Jane Street
New York
|
+$32.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$904K |
| 2 |
RAM
Roumell Asset Management
Chevy Chase,
Maryland
|
-$244K |
| 3 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
-$95K |
| 4 |
CSM
Central Square Management
Naperville,
Illinois
|
-$59K |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$45K |
PRTK Hedge Fund Activity: Q2 2014 in Review
36 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Paratek Pharmaceuticals, Inc. (PRTK) for Q2 2014, worth a combined $12.8M — down 38% from $20.6M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of PRTK and 4 opened new positions — a net loss of 3 holders — while 11 trimmed existing stakes and 9 added.
The largest buyer was Renaissance Technologies, adding an estimated $377K. The largest seller was Franklin Resources, exiting entirely with an estimated $904K sold.
- 36 institutional investors held Paratek Pharmaceuticals, Inc. (PRTK) as of Q2 2014, down from 39 in Q1 2014.
- Funds reported $12.8M of Paratek Pharmaceuticals, Inc. stock for Q2 2014, down 38% quarter-over-quarter.
- 4 funds opened new Paratek Pharmaceuticals, Inc. positions in Q2 2014 and 7 closed out, a net change of -3 holders.
- The largest Paratek Pharmaceuticals, Inc. buyer in Q2 2014 was Renaissance Technologies, an estimated $377K added.
- The largest Paratek Pharmaceuticals, Inc. seller in Q2 2014 was Franklin Resources, an estimated $904K sold.
Based on aggregated 13F filings for Q2 2014.